Jannie, P., Jensen, T. B., Schønning, K., Carlsen, T.
, Krarup, H. B., Christensen, P. B.
, Laursen, A. L., Bukh, J. & Weis, N. (2011).
Characterization of neutralizing antibodies in relation to treatment outcome in patients with chronic hepatitis C, genotype 1. Abstract fra AASLD 62nd Annual Meeting for the Study of Liver Diseases, San Francisco, USA.
Lohse, N., Gerstoft, J., Kronborg, G.
, Larsen, C. S., Pedersen, C.
, Pedersen, G., Nielsen, L.
, Sørensen, H. T. & Obel, N. (2011).
Comorbidity Acquired before HIV Diagnosis and Mortality in HIV-infected and Uninfected Persons: A Danish population-based cohort study.
JAIDS: Journal of Acquired Immune Deficiency Syndromes ,
57(4), 334-9.
https://doi.org/10.1097/QAI.0b013e31821d34ed
Lagging, M., Alsiö, A., Langeland, N., Pedersen, C., Färkkilä, M.
, Buhl, M. R., Mørch, K., Hellstrand, K. & Norkrans, G. (2011).
Early determination of hepatitis C virus RNA may help to decide the duration of therapy for chronic hepatitis C virus genotype 2/3 infection.
Hepatology,
53(3), 1067-8.
https://doi.org/10.1002/hep.23962Hansen, N., Obel, N., Christensen, P. B., Kjær, M.
, Laursen, A. L., Krarup, H. B., Møller, A., Schlichting, P., Bukh, J. O. D., Weis, N., the Danish Database for Hepatitis B and C (DANHEP)- group
& Nielsen, H. I. (2011).
Effectiveness of treatment with pegylated interferon and ribavirin in an unselected population of patients with chronic hepatitis C: A Danish nationwide cohort study.
B M C Infectious Diseases,
11(1), 177.
https://doi.org/10.1186/1471-2334-11-177Bukh, A., Melchjorsen, J., Offersen, R., Jensen, J. M. B., Nielsen, L. T., Støvring, H., Østergaard, L. J., Tolstrup, M. & Søgaard, O. S. (2011).
Endotoxemia Is Associated with Altered Innate and Adaptive Immune Responses in Untreated HIV-1 Infected Individuals.
PLoS One,
6(6), Artikel e21275.
https://doi.org/10.1371/journal.pone.0021275
Porskrog, A., Bjerregaard-Andersen, M., Oliveira, I., Joaquím, L. C., Camara, C.
, Andersen, P. L., Rabna, P., Aaby, P.
& Wejse, C. (2011).
Enhanced tuberculosis identification through 1-month follow-up of smear-negative tuberculosis suspects.
International Journal of Tuberculosis and Lung Disease,
15(4), 459-464.
https://doi.org/10.5588/ijtld.10.0353
Bannister, W. P., Cozzi-Lepri, A., Kjær, J., Clotet, B., Lazzarin, A., Viard, J.-P., Kronborg, G., Duiculescu, D., Beniowski, M., Machala, L., Phillips, A. & EuroSIDA group (Lars Østergaard, member) (2011).
Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.
Journal of Antimicrobial Chemotherapy,
66(4), 901-11.
https://doi.org/10.1093/jac/dkr006Rasmussen, T. A., Tolstrup, M., Melchjorsen, J., Frederiksen, C. A., Nielsen, U. S., Langdahl, B. L., Østergaard, L. J. & Laursen, A. L. (2011).
Evaluation of cardiovascular biomarkers In HIV-infected patients switching to abacavir or tenofovir based therapy.
B M C Infectious Diseases,
11, 267.
https://doi.org/10.1186/1471-2334-11-267